Literature DB >> 19429551

Influence of Ca(2+) ions on the activity of lantibiotics containing a mersacidin-like lipid II binding motif.

T Böttiger1, T Schneider, B Martínez, H-G Sahl, I Wiedemann.   

Abstract

Mersacidin binds to lipid II and thus blocks the transglycosylation step of the cell wall biosynthesis. Binding of lipid II involves a special motif, the so-called mersacidin-lipid II binding motif, which is conserved in a major subgroup of lantibiotics. We analyzed the role of Ca(2+) ions in the mode of action of mersacidin and some related peptides containing a mersacidin-like lipid II binding motif. We found that the stimulating effect of Ca(2+) ions on the antimicrobial activity known for mersacidin also applies to plantaricin C and lacticin 3147. Ca(2+) ions appear to facilitate the interaction of the lantibiotics with the bacterial membrane and with lipid II rather than being an essential part of a peptide-lipid II complex. In the case of lacticin 481, both the interaction with lipid II and the antimicrobial activity were Ca(2+) independent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429551      PMCID: PMC2704811          DOI: 10.1128/AEM.00262-09

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  47 in total

Review 1.  Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria.

Authors:  Yann Héchard; Hans Georg Sahl
Journal:  Biochimie       Date:  2002 May-Jun       Impact factor: 4.079

2.  The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics.

Authors:  Shang-Te D Hsu; Eefjan Breukink; Eugene Tischenko; Mandy A G Lutters; Ben de Kruijff; Robert Kaptein; Alexandre M J J Bonvin; Nico A J van Nuland
Journal:  Nat Struct Mol Biol       Date:  2004-09-12       Impact factor: 15.369

3.  Fluorescence and protein structure. X. Reappraisal of solvent and structural effects.

Authors:  R W Cowgill
Journal:  Biochim Biophys Acta       Date:  1967-01-18

4.  A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure.

Authors:  T Sashihara; H Kimura; T Higuchi; A Adachi; H Matsusaki; K Sonomoto; A Ishizaki
Journal:  Biosci Biotechnol Biochem       Date:  2000-11       Impact factor: 2.043

5.  Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin.

Authors:  Christiane Szekat; Ralph W Jack; Dirk Skutlarek; Harald Färber; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

6.  Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin.

Authors:  David Jung; Annett Rozek; Mark Okon; Robert E W Hancock
Journal:  Chem Biol       Date:  2004-07

7.  In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II-Gly5) of Staphylococcus aureus.

Authors:  Tanja Schneider; Maria Magdalena Senn; Brigitte Berger-Bächi; Alessandro Tossi; Hans-Georg Sahl; Imke Wiedemann
Journal:  Mol Microbiol       Date:  2004-07       Impact factor: 3.501

8.  Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity.

Authors:  Lili Xie; Leah M Miller; Champak Chatterjee; Olga Averin; Neil L Kelleher; Wilfred A van der Donk
Journal:  Science       Date:  2004-01-30       Impact factor: 47.728

9.  NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.

Authors:  Shang-Te D Hsu; Eefjan Breukink; Gabriele Bierbaum; Hans-Georg Sahl; Ben de Kruijff; Rob Kaptein; Nico A J van Nuland; Alexandre M J J Bonvin
Journal:  J Biol Chem       Date:  2003-01-31       Impact factor: 5.157

10.  The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate.

Authors:  T Schneider; K Gries; M Josten; I Wiedemann; S Pelzer; H Labischinski; H-G Sahl
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

View more
  8 in total

1.  Peptide antibiotic sensing and detoxification modules of Bacillus subtilis.

Authors:  Anna Staroń; Dora Elisabeth Finkeisen; Thorsten Mascher
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Cell Wall-active Bacteriocins and Their Applications Beyond Antibiotic Activity.

Authors:  Clara Roces; Ana Rodríguez; Beatriz Martínez
Journal:  Probiotics Antimicrob Proteins       Date:  2012-12       Impact factor: 4.609

3.  Antibacterial Peptides: Opportunities for the Prevention and Treatment of Dental Caries.

Authors:  Adam Pepperney; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06       Impact factor: 4.609

4.  Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors.

Authors:  Anna Müller; Daniela Münch; Yvonne Schmidt; Katrin Reder-Christ; Guido Schiffer; Gerd Bendas; Harald Gross; Hans-Georg Sahl; Tanja Schneider; Heike Brötz-Oesterhelt
Journal:  J Biol Chem       Date:  2012-04-18       Impact factor: 5.157

Review 5.  Cell wall homeostasis in lactic acid bacteria: threats and defences.

Authors:  Beatriz Martínez; Ana Rodríguez; Saulius Kulakauskas; Marie-Pierre Chapot-Chartier
Journal:  FEMS Microbiol Rev       Date:  2020-09-01       Impact factor: 16.408

6.  Genomic and proteomic comparisons of bacteriocins in probiotic species Lactobacillus and Bifidobacterium and inhibitory ability of Escherichia coli MG 1655.

Authors:  Nasrin Darvishi; Najaf Allahyari Fard; Maryam Sadrnia
Journal:  Biotechnol Rep (Amst)       Date:  2021-06-22

7.  Non-proteinogenic amino acids in lacticin 481 analogues result in more potent inhibition of peptidoglycan transglycosylation.

Authors:  Patrick J Knerr; Trent J Oman; Chantal V Garcia De Gonzalo; Tania J Lupoli; Suzanne Walker; Wilfred A van der Donk
Journal:  ACS Chem Biol       Date:  2012-09-04       Impact factor: 5.100

8.  New insights into the mode of action of the lantibiotic salivaricin B.

Authors:  Abdelahhad Barbour; John Tagg; Osama K Abou-Zied; Koshy Philip
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.